Demographic, physical characteristics, and laboratory results of the cohort of men with sickle cell anemia enrolled in the priapism study (n = 73)
| Characteristic∗ . | Summary statistics . |
|---|---|
| Age, y | 24.0 (21.5-28.5) |
| Marital status, married | 7 (9.6) |
| BMI, kg/m2 | 17.9 (16.6-18.8) |
| Systolic blood pressure, mm Hg | 110.0 (104.5-117.0) |
| Diastolic blood pressure, mm Hg | 63.0 (56.0-68.5) |
| On hydroxyurea | 11 (15.1) |
| Total hemoglobin, g/dL | 8.0 (6.9-9.6) |
| Mean cell volume, fl | 84.9 (80.4-92.7) |
| Percent hemoglobin, F% | 4.6 (2.8-8.8) |
| Percent hemoglobin, S% | 85.6 (80.6-88.0) |
| White blood cell count, 109/L | 13.3 (9.6-17.6) |
| Absolute neutrophil count, 109/L | 6.45 (4.55-86.0) |
| Platelet count, 109/L | 297.0 (222.5-363.5) |
| Lactate dehydrogenase, U/L | 540.0 (379.0-729.0) |
| Total bilirubin, mg/dL | 79.0 (46.5-125.5) |
| Direct conjugated bilirubin, mg/dL | 16.0 (11.5-24.0) |
| Indirect unconjugated bilirubin, mg/dL | 79.0 (46.5-125.5) |
| Aspartate aminotransferase, IU | 46.0 (34.5-59.0) |
| Alanine aminotransferase, IU | 17.0 (13.0-25.5) |
| Alkaline phosphatase, IU | 98.0 (75.5-128.0) |
| Albumin, g/L | 42.0 (40.0-45.0) |
| Globulin, g/L | 38.0 (34.0-43.0) |
| Testosterone, ng/dL | 8.1 (6.4-10.1) |
| Follicles stimulating hormone, mlU/mL | 5.6 (4.0-7.3) |
| Luteinizing hormone, mlU/mL | 7.2 (5.5-9.9) |
| Creatinine, μmol/L | 59.0 (52.5-85.0) |
| Urea | 2.8 (2.3-5.2) |
| Proteinuria, positive | 26 (35.6) |
| eGFR, mL/min/1.73 m2 | 155.0 (128.0-166.7) |
| Stroke, n (%) | 3 (4.1) |
| Leg ulcer, n (%) | 3 (4.1) |
| Avascular necrosis | 11 (15.1) |
| Malaria, n (%) | 55 (75) |
| Blood transfusion, n (%) | 25 (34.2) |
| Characteristic∗ . | Summary statistics . |
|---|---|
| Age, y | 24.0 (21.5-28.5) |
| Marital status, married | 7 (9.6) |
| BMI, kg/m2 | 17.9 (16.6-18.8) |
| Systolic blood pressure, mm Hg | 110.0 (104.5-117.0) |
| Diastolic blood pressure, mm Hg | 63.0 (56.0-68.5) |
| On hydroxyurea | 11 (15.1) |
| Total hemoglobin, g/dL | 8.0 (6.9-9.6) |
| Mean cell volume, fl | 84.9 (80.4-92.7) |
| Percent hemoglobin, F% | 4.6 (2.8-8.8) |
| Percent hemoglobin, S% | 85.6 (80.6-88.0) |
| White blood cell count, 109/L | 13.3 (9.6-17.6) |
| Absolute neutrophil count, 109/L | 6.45 (4.55-86.0) |
| Platelet count, 109/L | 297.0 (222.5-363.5) |
| Lactate dehydrogenase, U/L | 540.0 (379.0-729.0) |
| Total bilirubin, mg/dL | 79.0 (46.5-125.5) |
| Direct conjugated bilirubin, mg/dL | 16.0 (11.5-24.0) |
| Indirect unconjugated bilirubin, mg/dL | 79.0 (46.5-125.5) |
| Aspartate aminotransferase, IU | 46.0 (34.5-59.0) |
| Alanine aminotransferase, IU | 17.0 (13.0-25.5) |
| Alkaline phosphatase, IU | 98.0 (75.5-128.0) |
| Albumin, g/L | 42.0 (40.0-45.0) |
| Globulin, g/L | 38.0 (34.0-43.0) |
| Testosterone, ng/dL | 8.1 (6.4-10.1) |
| Follicles stimulating hormone, mlU/mL | 5.6 (4.0-7.3) |
| Luteinizing hormone, mlU/mL | 7.2 (5.5-9.9) |
| Creatinine, μmol/L | 59.0 (52.5-85.0) |
| Urea | 2.8 (2.3-5.2) |
| Proteinuria, positive | 26 (35.6) |
| eGFR, mL/min/1.73 m2 | 155.0 (128.0-166.7) |
| Stroke, n (%) | 3 (4.1) |
| Leg ulcer, n (%) | 3 (4.1) |
| Avascular necrosis | 11 (15.1) |
| Malaria, n (%) | 55 (75) |
| Blood transfusion, n (%) | 25 (34.2) |
Median (inter-quartile range) for continuous variables and counts (percentages) for categorical variables. BMI, body mass index; eGFR, estimated glomerular filtration rate (derived using CKD-EPI Creatinine Equation 2021).